Navigation Links
Scioderm's SD-101 Receives Breakthrough Therapy Designation from FDA for Treatment of Epidermolysis Bullosa
Date:4/29/2013

al trial, SD-101 application resulted in complete closure of 88% of target chronic lesions within one month, in addition to a 57% reduction in BSA coverage of lesions and erosions after 3 months of daily treatment.   SD-101 was well tolerated by the children, with daily administration up to 3 months.

About Scioderm

Scioderm is a privately held, clinical-stage pharmaceutical company focused on developing topical products to address critical medical needs in the treatment of chronic skin diseases.  The company is headquartered in Durham, North Carolina.  Additional information about Scioderm can be found at www.sderm.com

Scioderm Forward Looking Statement

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including: our dependence on third parties for the development, regulatory approval and successful commercialization of our products, the inherent risk of failure in developing product candidates based on new technologies, risks associated with the costs of clinical development efforts, as well as other risks.  Actual results may differ materially from those projected.  These forward-looking statements represent our judgment as of the date of the release.  Scioderm disclaims any intent or obligation to update these forward-looking statements.

Company Contact
Dr. Robert Ryan
Chief Executive Officer
robert.ryan@sderm.com
(919) 274-0703 

Media Contact: Dr. Robert Ryan , Scioderm, LLC, 919-274-0703, robert.ryan@sderm.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com
'/>"/>

SOURCE Scioderm, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Scioderm Announces Positive Phase II Data of Topical SD-101 on Wound Closure and Reduction of Lesions and Blisters in Children with Epidermolysis Bullosa (EB)
2. Scioderms Investigational New Drug (IND) Application for SD-101 for Treatment of Epidermolysis Bullosa (EB) Allowed by the FDA
3. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
4. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
5. Nephros Receives 510(k) Clearance for Hemodiafiltration System
6. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
7. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
8. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
9. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
10. Alexza Receives Complete Response Letter for Adasuve™ NDA
11. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... July 20, 2015 Research and Markets ( ... "Medical Device Regulation in Asia/Pacific Markets Seminar" conference ... European Medical Device market is well established, the next ... China , together with other countries in ... process of implementing, their own medical device regulations. This ...
(Date:7/27/2015)... July 17, 2015 Research and Markets ... the "G-Protein Coupled Receptors Market: Global Industry ... - 2022" report to their offering. ... segmented based on of assay type, therapeutic area, ... market has been categorized into six major segments: ...
(Date:7/27/2015)... FORT WORTH, Texas , July 27, 2015 /PRNewswire/ ... Report "Global In Situ Hybridization Market Study (2014-2019) by ... Immunology, Neurosciences, Cytology, Others), By End User (Hospitals, Pharma ... hybridization market was valued at $554.4 million 2014 and ... a CAGR of 4.2% during the forecast period, 2014 ...
Breaking Medicine Technology:Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 3
(Date:7/28/2015)... ... July 28, 2015 , ... Want to improve your ... or in your easy chair? Luckily, there are plenty of back-friendly cardio exercises that ... orthopedic spine surgeon at Atlantic Spine Center . , It’s simply untrue ...
(Date:7/27/2015)... ... July 28, 2015 , ... Almost a year ago, ... offer behavioral health counseling for persons who are obese and those who are overweight ... clear. , That mandate will affect any commercial health plan with a program year ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of ... the NAPW VIP Woman of the Year Circle. She is recognized with this prestigious ... Local Chapters, NAPW is the nation’s leading networking organization exclusively for professional women. , ...
(Date:7/27/2015)... ... , ... The heroin epidemic is affecting the Charlotte in North Carolina equally ... rate for heroin usage has continued to climb around the country in part because ... alternative for those with an addiction to prescription opiate medications. According to WCNC, the ...
(Date:7/27/2015)... ... 27, 2015 , ... Looking to brush up on all the things you ... New Jersey has enhanced its Dental webpage with new materials, including user-friendly, educational videos, ... “Horizon is committed to offering our 3.8 million members tools and resources to help ...
Breaking Medicine News(10 mins):Health News:Safe Cardio for Back Pain Sufferers 2Health News:Safe Cardio for Back Pain Sufferers 3Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3Health News:Thinking about a Dental Check-up? Check out Horizon Blue Cross Blue Shield of New Jersey’s Enhanced Website for a Dental Download of Helpful Information 2
... , FORT LEE, N.J., Aug. 14 ... http://inflation.us members: , , "We believe the violence ... of things to come. These meetings will likely get louder and more ... plan to socialize health care in America, the violence could potentially escalate ...
... the top 10 hospital systems in the United States based ... and professional information organization based in New York. ... peers by a wide margin. They provided better care, ... fewer patient complications, and made fewer patient safety errors. ...
... Aug. 14 Former Congressman J.C. Watts will join ... a press conference to discuss a new poll commissioned by the ... sheds light on specialty physicians, opinions of health-care reform proposals and ... insurance program. , , , ...
... , NOVATO, Calif., Aug. 14 ... of video and text relay services, and professional interpreting for deaf, ... the second quarter ended June 30, 2009. On August 13, 2009, ... Quarterly Report on Form 10-Q for the quarter ended June 30, ...
... Implantation in people at risk for stroke could reduce ... News) -- Closing the heart,s left atrial appendage could ... with non-valvular atrial fibrillation who are at risk for ... the most common type of irregular heartbeat, causes the ...
... SOMERSET, N.J., Aug. 14 - TeamStaff, Inc. (Nasdaq: ... services, today announced its financial results for the third quarter ended ... revenues for the three months ended June 30, 2009 were $13.1 ... year and $13.7 million in the prior quarter ended March 31, ...
Cached Medicine News:Health News:Violence at Town Hall Meetings Could Escalate 2Health News:Violence at Town Hall Meetings Could Escalate 3Health News:University Hospitals in Cleveland named one of the top 10 hospital systems in United States 2Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 2Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 3Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 4Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 5Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 6Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 7Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 8Health News:Device May Offer Alternative to Warfarin for Arrhythmia 2Health News:TeamStaff Reports Third Quarter Results 2Health News:TeamStaff Reports Third Quarter Results 3Health News:TeamStaff Reports Third Quarter Results 4Health News:TeamStaff Reports Third Quarter Results 5Health News:TeamStaff Reports Third Quarter Results 6Health News:TeamStaff Reports Third Quarter Results 7Health News:TeamStaff Reports Third Quarter Results 8Health News:TeamStaff Reports Third Quarter Results 9Health News:TeamStaff Reports Third Quarter Results 10Health News:TeamStaff Reports Third Quarter Results 11Health News:TeamStaff Reports Third Quarter Results 12Health News:TeamStaff Reports Third Quarter Results 13Health News:TeamStaff Reports Third Quarter Results 14
This design features a solid red iris....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Sphere Introducer...
Reusable cannula with .90 mm (20 g) shaft, tapering to .30 mm (30 g). Angled 125 3 mm from tip and flattened for easy insertion into the subretinal space....
Medicine Products: